Form 4: Innoviva CAO Marianne Zhen Reports Stock Withholding

Innoviva Chief Accounting Officer Marianne Zhen reported the withholding of 1,127 shares to cover tax obligations related to equity vesting.

Summary

• Chief Accounting Officer Marianne Zhen disposed of 1,127 shares of Innoviva, Inc. common stock.
• The transaction occurred on May 20, 2026, at a price of $22.24 per share.
• The disposal was a mandatory withholding by the issuer to satisfy tax obligations associated with the vesting of employee equity grants.
• Following this transaction, the reporting person maintains beneficial ownership of 57,516 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative event, as the share reduction was purely for tax compliance purposes rather than a discretionary sale.

Positives

• The transaction reflects the vesting of previously granted employee equity, indicating ongoing compensation alignment.

Negatives

• The transaction resulted in a reduction of the reporting person's direct share ownership.

Risks

• No specific operational or financial risks were disclosed in this ownership filing.

Future Outlook

No forward-looking guidance or strategic outlook was provided in this filing.

Management Comments

• The shares were withheld by the Issuer to satisfy income tax withholding obligations associated with the quarterly vesting of previously granted employee equity grants.

Industry Context

StockSavvy.ai notes that this is a routine administrative filing common in the biotechnology and pharmaceutical sectors, where equity-based compensation is a standard component of executive remuneration packages.

Comparison to Industry Standards

• The transaction follows standard corporate governance practices for tax withholding on vested equity awards.
• The reporting of such transactions is consistent with SEC Section 16(a) requirements for executive officers.

Stakeholder Impact

• Minimal impact on shareholders as the transaction was a standard tax-related equity withholding.

Next Steps

• No future actions or milestones were disclosed.

Key Dates

Keywords

Innoviva, INVA, Form 4, Insider Trading, Equity Vesting, Chief Accounting Officer